These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice. Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052 [TBL] [Abstract][Full Text] [Related]
8. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773 [TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [ Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625 [TBL] [Abstract][Full Text] [Related]
11. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. Chanet A; Milenkovic D; Deval C; Potier M; Constans J; Mazur A; Bennetau-Pelissero C; Morand C; Bérard AM J Nutr Biochem; 2012 May; 23(5):469-77. PubMed ID: 21684135 [TBL] [Abstract][Full Text] [Related]
12. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques. Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862 [TBL] [Abstract][Full Text] [Related]
13. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice. Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156 [TBL] [Abstract][Full Text] [Related]
15. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet. Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759 [TBL] [Abstract][Full Text] [Related]
16. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Coenen KR; Hasty AH Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116 [TBL] [Abstract][Full Text] [Related]
17. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice. Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426 [TBL] [Abstract][Full Text] [Related]
18. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Tsimikas S; Shortal BP; Witztum JL; Palinski W Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392 [TBL] [Abstract][Full Text] [Related]